This Article Full Text Full Text (PDF) Supplemental material Other Versions of this Article: MCB.02136-06v1 27/16/5746    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bilanges, B. Articles by Stokoe, D. Search for Related Content PubMed PubMed Citation Articles by Bilanges, B. Articles by Stokoe, D.

Tuberous Sclerosis Complex Proteins 1 and 2 Control Serum-Dependent Translation in a TOP-Dependent and -Independent Manner ^,

Cancer Research Institute, University of California, San Francisco, California,¹ Agilent Technologies, Inc., Santa Clara, California²

Received 14 November 2006/ Returned for modification 30 January 2007/ Accepted 17 May 2007

The tuberous sclerosis complex (TSC) proteins TSC1 and TSC2 regulate protein translation by inhibiting the serine/threonine kinase mTORC1 (for mammalian target of rapamycin complex 1). However, how TSC1 and TSC2 control overall protein synthesis and the translation of specific mRNAs in response to different mitogenic and nutritional stimuli is largely unknown. We show here that serum withdrawal inhibits mTORC1 signaling, causes disassembly of translation initiation complexes, and causes mRNA redistribution from polysomes to subpolysomes in wild-type mouse embryo fibroblasts (MEFs). In contrast, these responses are defective in Tsc1^–/– or Tsc2^–/– MEFs. Microarray analysis of polysome- and subpolysome-associated mRNAs uncovered specific mRNAs that are translationally regulated by serum, 90% of which are TSC1 and TSC2 dependent. Surprisingly, the mTORC1 inhibitor, rapamycin, abolished mTORC1 activity but only affected 40% of the serum-regulated mRNAs. Serum-dependent signaling through mTORC1 and polysome redistribution of global and individual mRNAs were restored upon re-expression of TSC1 and TSC2. Serum-responsive mRNAs that are sensitive to inhibition by rapamycin are highly enriched for terminal oligopyrimidine and for very short 5' and 3' untranslated regions. These data demonstrate that the TSC1/TSC2 complex regulates protein translation through mainly mTORC1-dependent mechanisms and implicates a discrete profile of deregulated mRNA translation in tuberous sclerosis pathology.

Published ahead of print on 11 June 2007.

Supplemental material for this article may be found at http://mcb.asm.org/.

This article has been cited by other articles:

• Oliere, S., Arguello, M., Mesplede, T., Tumilasci, V., Nakhaei, P., Stojdl, D., Sonenberg, N., Bell, J., Hiscott, J. (2008). Vesicular Stomatitis Virus Oncolysis of T Lymphocytes Requires Cell Cycle Entry and Translation Initiation. J. Virol. 82: 5735-5749 [Abstract] [Full Text]  
• Meikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M., Kwiatkowski, D. J. (2008). Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function. J. Neurosci. 28: 5422-5432 [Abstract] [Full Text]  
• Dowling, R. J.O., Zakikhani, M., Fantus, I. G., Pollak, M., Sonenberg, N. (2007). Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells. Cancer Res. 67: 10804-10812 [Abstract] [Full Text]